1. Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization
   Kevin B. Teuscher et al, 2022, Journal of Medicinal Chemistry CrossRef
2. Proteomic Analysis Reveals Molecular Differences in the Development of Gastric Cancer
   Rinchen Dhondrup et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
3. Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
   Qi Xia et al, 2020, Frontiers in Genetics CrossRef
4. Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors
   Kevin B. Teuscher et al, 2023, Journal of Medicinal Chemistry CrossRef
5. Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective
   Xin Chen et al, 2021, Journal of Medicinal Chemistry CrossRef